Top Markets
Coin of the day
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

IXSBF
Clasificación en acciones #41697
InNexus Biotechnology, Inc. is a development-stage company dedicated to... InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treating B-cell non-Hodgkin's lymphoma (NHL). DXLr120: A recombinant DXL anti-CD20 antibody also being developed for B-cell NHL. DXL702: A monoclonal antibody targeting metastatic breast cancer. DXL1218: An agent designed to target the epidermal growth factor receptor (EGFR), an antigen frequently overexpressed in metastatic colorectal cancer and squamous cell carcinomas of the head and neck. The company also maintains strategic partnerships with XERIS Pharmaceuticals, Genhelix, Evogenix, Affimed, and Corixa. InNexus Biotechnology, Inc. is based in Vancouver, Canada.
Precio por acción
$0.0001
Última sincronización: 2025-11-07
Capitalización bursátil
$12.63K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio InNexus Biotechnology, Inc. (IXSBF)

Categoría

Historial del precio de la acción de InNexus Biotechnology, Inc. (IXSBF)
Precio más alto de cierre: $0.00 el 2025-11-01

Precio más bajo de cierre: $0.54 el 2005-01-01
Historial del precio de la acción de InNexus Biotechnology, Inc. desde 2005 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 0.00%
2024 9,900.00%
2023 -98.02%
2022 -49.50%
2021 809.09%
2020 1,000.00%
2019 -99.00%
2018 0.00%
2017 0.00%
2016 20.00%
2015 -89.80%
2014 45.43%
2013 -9.43%
2012 -75.12%
2011 -93.68%
2010 -30.02%
2009 -1.01%
2008 -76.04%
2007 -65.32%
2006 182.90%
2005 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$59.08 62.03%
US
$49.68 72.21%
SE
$184.45 43.36%
FR
$62.39 4.91%
IT
$113.04 55.27%
US